Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study of Tamsulosin 0.4 mg Sustained Release Film Coated Tablet Produced by PT Dexa Medica in Comparison With The Comparator Drug (Harnal® Ocas 0.4 mg Prolonged Release Tablet Produced by Astellas Pharma Europe B.V., The Netherlands, Imported by PT Combiphar, Indonesia) When Administered Under Fasting Condition in Healthy Subjects

NCT06558032 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.

NCT NCT06558032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06558032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study of Tamsulosin 0.4 mg Sustained Release Film Coated Tablet Produced by PT Dexa Medica in Comparison With The Comparator Drug (Harnal® Ocas 0.4 mg Prolonged Release Tablet Produced by Astellas Pharma Europe B.V., The Netherlands, Imported by PT Combiphar, Indonesia) When Administered Under Fasting Condition in Healthy Subjects
Lead sponsor
Dexa Medica Group
Phase
Phase 1
Overall status
Completed
Start date
November 6, 2023
Completion date
February 7, 2024
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy